Advertisement
Advertisement
Atectura Breezhaler

Atectura Breezhaler Description

Manufacturer:

Novartis

Distributor:

Zuellig Pharma

Marketer:

A. Menarini
Full Prescribing Info
Description
Atectura Breezhaler 150 micrograms/80 micrograms inhalation powder, hard capsules: Each capsule contains 150 mcg of indacaterol (as acetate) and 80 mcg of mometasone furoate.
Each delivered dose (the dose that leaves the mouthpiece of the inhaler) contains 125 mcg of indacaterol (as acetate) and 62.5 mcg of mometasone furoate.
Atectura Breezhaler 150 micrograms/160 micrograms inhalation powder, hard capsules: Each capsule contains 150 mcg of indacaterol (as acetate) and 160 mcg of mometasone furoate.
Each delivered dose (the dose that leaves the mouthpiece of the inhaler) contains 125 mcg of indacaterol (as acetate) and 127.5 mcg of mometasone furoate.
Atectura Breezhaler 150 micrograms/320 micrograms inhalation powder, hard capsules: Each capsule contains 150 mcg of indacaterol (as acetate) and 320 mcg of mometasone furoate.
Each delivered dose (the dose that leaves the mouthpiece of the inhaler) contains 125 mcg of indacaterol (as acetate) and 260 mcg of mometasone furoate.
Excipient(s) with known effect: Each capsule contains approximately 25 mg of lactose monohydrate.
Excipients/Inactive Ingredients: Capsule content: Lactose monohydrate.
Capsule shell: Gelatin, Printing ink.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement